Filing Details
- Accession Number:
- 0001127602-25-019590
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-25 16:16:45
- Reporting Period:
- 2025-07-23
- Filing Date:
- 2025-07-25
- Accepted Time:
- 2025-07-25 16:16:45
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554880 | Iii Mcclain John Holmes | 1100 N. Wood Dale Road Wood Dale IL 60191 | Chairman, President & Ceo | Yes | Yes | No | No |
Transaction Summary
| Sold: | 56,551 shares | Avg. Price: $77.73 | Total Value: $4,395,641.32 |
| Number of Shares After Transactions: | 360,921 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-07-23 | 14,595 | $0.00 | 342,141 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-07-23 | 43,780 | $0.00 | 385,921 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-07-23 | 25,000 | $77.34 | 360,921 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-07-24 | 25,000 | $48.09 | 385,921 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-07-24 | 25,000 | $78.02 | 360,921 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-07-24 | 6,551 | $48.09 | 367,472 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-07-24 | 6,551 | $78.10 | 360,921 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Acquisiton | 2025-07-23 | 40,380 | $79.45 | 40,380 | $79.45 |
| Common Stock | Stock Option | Disposition | 2025-07-24 | 25,000 | $0.00 | 25,000 | $48.09 |
| Common Stock | Stock Option | Disposition | 2025-07-24 | 6,551 | $0.00 | 6,551 | $48.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,380 | 2026-07-31 | 2035-07-23 | No | 4 | A | Direct |
| 57,300 | 2019-07-31 | 2028-07-09 | No | 4 | M | Direct |
| 50,749 | 2019-07-31 | 2028-07-09 | No | 4 | M | Direct |
Footnotes
- Award of stock pursuant to a Restricted Stock Agreement in a transaction exempt under Rule 16b-3.
- Award of stock pursuant to a Performance Restricted Stock Agreement in a transaction exempt under Rule 16b-3.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.48 to $78.48 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.04 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.26 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The awarded stock option vests and becomes exercisable in 1/3 annual installments beginning on July 31, 2026 and shall vest as follows: 33 and 1/3% on each of July 31, 2026, July 31, 2027, and July 31, 2028.
- The awarded stock option vested and became exercisable in 1/3 annual installments beginning on July 31, 2019 and vested as follows: 33 and 1/3% on each of July 31, 2019, July 31, 2020, and July 31, 2021.
Billionaire Hedge Funds
